175 related articles for article (PubMed ID: 2563750)
1. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
Kornhuber J; Riederer P; Reynolds GP; Beckmann H; Jellinger K; Gabriel E
J Neural Transm; 1989; 75(1):1-10. PubMed ID: 2563750
[TBL] [Abstract][Full Text] [Related]
2. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
Mjörndal T; Winblad B
Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
[TBL] [Abstract][Full Text] [Related]
3. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
4. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptors in substantia nigra in schizophrenia.
Owen R; Owen F; Poulter M; Crow TJ
Brain Res; 1984 May; 299(1):152-4. PubMed ID: 6144367
[TBL] [Abstract][Full Text] [Related]
6. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
[TBL] [Abstract][Full Text] [Related]
7. Striatal binding of 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding.
Andersson U; Eckernäs SA; Hartvig P; Ulin J; Långström B; Häggström JE
J Neural Transm Gen Sect; 1990; 79(3):215-26. PubMed ID: 2137000
[TBL] [Abstract][Full Text] [Related]
8. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
Reynolds GP; Rossor MN; Iversen LL
J Neural Transm Suppl; 1983; 18():273-7. PubMed ID: 6135746
[TBL] [Abstract][Full Text] [Related]
9. Increased brain dopamine and dopamine receptors in schizophrenia.
Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
[TBL] [Abstract][Full Text] [Related]
10. Chemical and structural changes in the brain in patients with movement disorder.
Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Johnstone EC; Owen F; Owens DG; Poulter M
Psychopharmacology Suppl; 1985; 2():104-10. PubMed ID: 2860653
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
[TBL] [Abstract][Full Text] [Related]
12. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.
Arora RC; Meltzer HY
J Neural Transm Gen Sect; 1991; 85(1):19-29. PubMed ID: 1678267
[TBL] [Abstract][Full Text] [Related]
13. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
[TBL] [Abstract][Full Text] [Related]
14. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Seeman P
Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
[TBL] [Abstract][Full Text] [Related]
15. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
Coccini T; Manzo L; Costa LG
Immunopharmacology; 1991; 22(2):93-105. PubMed ID: 1662188
[TBL] [Abstract][Full Text] [Related]
16. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
[TBL] [Abstract][Full Text] [Related]
17. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
[TBL] [Abstract][Full Text] [Related]
18. 3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.
Cross AJ; Crow TJ; Owen F
Psychopharmacology (Berl); 1981; 74(2):122-4. PubMed ID: 6791218
[TBL] [Abstract][Full Text] [Related]
19. 3H-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect of neuroleptic treatment.
Laufer N; Spivak B; Holdengreber V; Zipser J; Kosower N; Ragolsky M; Weizman A
Clin Neuropharmacol; 1999; 22(2):110-4. PubMed ID: 10202608
[TBL] [Abstract][Full Text] [Related]
20. Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.
Ruiz J; Gabilondo AM; Meana JJ; García-Sevilla JA
Psychopharmacology (Berl); 1992; 109(4):410-4. PubMed ID: 1365855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
